Revolutionary Cancer Vaccine to Be Tested on Humans

There is a team that is behind the Oxford-AstraZeneca Covid vaccine that is going to be testing a cancer treatment that is based on the technology behind the vaccine. It will be tested on humans for the first time after they got impressive results from animal experiments.
If effective this cancer vaccine would be revolutionary in that it might be able to be used to shrink tumours which they've already seen in mice experiments. It is designed to ultimately turn the person's immune system against the cancer.

It is estimated that roughly 39.5% of men and women might at some point be diagnosed with cancer, according to data from the National Cancer Institute. In a number of circumstances it is early detection that can help the most but for many Americans today they miss cancer screenings and the pandemic didn't help things either on that front.

Upcoming Human Trials
Now there is going to be upcoming human trials for the cancer vaccine that already looks promising. For that first study with human trials they will be going with participants who have a form of non-small cell lung cancer. It will be the Oxford team working on this study with the Ludwig Institute of Cancer Research. If they are successful this could mean big changes overall for cancer treatment in the market today.

Most common cancer therapies: surgery, chemotherapy, and radiation.

Still today we see that the common therapies that are tried for patients struggling with cancer are those like chemo, surgery, or radiation, but they aren't the only options.

The technology behind this cancer vaccine, researchers suggest, might be helpful in the future in dealing with a range of cancers. That technology, referred to as "viral vector" could do big things to change the market for cancer treatment if it proves to be successful.